• Home
  • Legislature(2023 - 2024)
  • Meetings
Legislature(2023 - 2024)BELTZ 105 (TSBldg)

03/20/2024 01:30 PM Senate LABOR & COMMERCE

Note: the audio and video recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.

Download Mp3. <- Right click and save file as

Audio Topic
01:35:49 PM Start
01:36:51 PM SB196
01:43:46 PM SB121
02:26:15 PM Adjourn
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+= SB 196 EMPLOYER DRUG AND ALCOHOL TESTING TELECONFERENCED
Moved SB 196 Out of Committee
-- Public Testimony <Time Limit May Be Set> --
+= SB 121 PHARMACIES/PHARMACISTS/BENEFITS MANAGERS TELECONFERENCED
Heard & Held
-- Invited & Public Testimony --
-- Public Testimony <Time Limit May Be Set> --
**Streamed live on AKL.tv**
Document Name Date/Time Subjects
SSSB121 Public Testimony-Letter_NABIP 03.20.24.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Public Testimony-Letter_PHC 03.09.24.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 DCCED-DOI Applicable Court Cases in Oklahoma and Arkansas 03.12.24.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Mulready 10th Circuit Decision.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Public Testimony-Dianne Holmes 03.14.24.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 121
SB196 ver A.pdf SL&C 3/8/2024 1:30:00 PM
SL&C 3/20/2024 1:30:00 PM
 		SB 196
SB196 Sponsor Statement Version A.pdf SL&C 3/8/2024 1:30:00 PM
SL&C 3/20/2024 1:30:00 PM
 		SB 196
SB196 Sectional Analysis Version A.pdf SL&C 3/8/2024 1:30:00 PM
SL&C 3/20/2024 1:30:00 PM
 		SB 196
SB196 Fiscal Note-DOLWD-WH 03.02.24.pdf SL&C 3/8/2024 1:30:00 PM
SL&C 3/20/2024 1:30:00 PM
 		SB 196
SSSB121 Sectional Analysis ver H 02.12.24.pdf SL&C 2/28/2024 1:30:00 PM
SL&C 3/11/2024 1:30:00 PM
SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Sponsor Statement 02.11.24.pdf SL&C 2/28/2024 1:30:00 PM
SL&C 3/11/2024 1:30:00 PM
SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Fiscal Note-DCCED-CBPL-02.23.24.pdf SL&C 2/28/2024 1:30:00 PM
SL&C 3/11/2024 1:30:00 PM
SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Fiscal Note-DCCED-DOI-02.23.24.pdf SL&C 2/28/2024 1:30:00 PM
SL&C 3/11/2024 1:30:00 PM
SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 ver H.pdf SL&C 2/28/2024 1:30:00 PM
SL&C 3/11/2024 1:30:00 PM
SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Fiscal Note-DOA-DRB 02.24.24.pdf SL&C 2/28/2024 1:30:00 PM
SL&C 3/11/2024 1:30:00 PM
SL&C 3/20/2024 1:30:00 PM
 		SB 121
SB196 Public Testimony-Letter-RDC 02.29.24.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 196
SSSB121 Public Testimony APRN Alliance 03.17.24.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Public Testimony Nat. Psoriasis Foundation 03.15.24.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Public Testimony Albertsons 03.19.24.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Intro Slides Giessel 3-20-24.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Public Testimony-CVS Brenda Snyder 03.20.24.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 121
SSSB121 Public Testimony ACPA 03.11.24.pdf SL&C 3/20/2024 1:30:00 PM
 		SB 121